Ideaya Plans Accelerated Approval Filing Of Darovasertib On Positive Phase II/III Data

 
• By Joseph Haas
  
Ideaya's combo regimen for uveal melanoma may be ready for an FDA filing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Trial Results

More from R&D